Niche market Indose operates at the intersection of medical devices and cannabis, offering a dosage-measuring vaporizer. This presents a sales opportunity to medical cannabis clinics, prescription-based dispensaries, and regulatory-compliant cannabis programs seeking precise dosing solutions for patients.

Series A traction With a $3.5M Series A led by Casa Verde, Indose has demonstrated investor confidence and market validation. Leverage this credibility to approach strategic partners, venture-backed cannabis tech platforms, and potential distributors looking for proven startups with room to scale.

Low headcount Small team size (2-10 employees) suggests lean operations but potential bandwidth constraints. This indicates a need for channel partnerships, white-label opportunities, or distribution alliances to accelerate go-to-market and field support without overburdening internal resources.

Revenue upside Current revenue is under one million with total funding around four plus million dollars. Focus on upsell and expansion into adjacent medical devices or cannabis delivery ecosystems, as well as multi-state regulatory markets where precise dosing is valued by patients and clinicians.

Tech-enabled product The device relies on digital dosing measurement and real-time display, supported by a robust tech stack (AWS, Webflow, WordPress, Google Workspace). This opens opportunities for B2B collaborations with digital health platforms, data analytics firms, and pharmacy/dispensing software providers seeking integrated dose-tracking capabilities.